AGM Information • Apr 30, 2024
AGM Information
Open in ViewerOpens in native device viewer

Trine Teigland (Board member) and Lutz Heinemann (Board member) were re-elected and Tone Kvåle (Board member) was elected as new member of the BoD as proposed by the Nomination Committee. No alternative candidates were proposed.
All proposals on the agenda were adopted, cf. the notification of the Annual General Meeting that was published on Oslo Stock Exchange on 16. April 2024. The complete minutes of the Annual General Meeting are attached and will be available on https://lifecare.no/investor-relations/
Lifecare AS is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's main focus is to bring the next generation of Continuous Glucose Monitoring ("CGM") systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on the sensor body for read-out of pressure variations. Lifecare's sensor technology is referred to as "Sencell" and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
For further information, please contact:
Joacim Holter, CEO, Lifecare AS, [email protected], +47 40 05 90 40
Asle Wingsternes, Head of Communications & Public Affairs, [email protected], +47 41 61 42 52
This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication at 2024-04-30 15:40 CEST.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.